We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$148B
AUM Growth
+$13.7B
Cap. Flow
+$2.5B
Cap. Flow %
1.69%
Top 10 Hldgs %
25.2%
Holding
4,104
New
267
Increased
1,933
Reduced
1,554
Closed
192

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$292M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$253M
3
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$230M
4
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$156M
5
DXCM icon
DexCom
DXCM
+$107M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$233M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$137M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$89.9M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$85.1M

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Financials 9.11%
3 Healthcare 8.03%
4 Industrials 6.97%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HYLN icon
3851
Hyliion Holdings
HYLN
$699M
$19.5K ﹤0.01%
11,100
– –
CGTX icon
3852
Cognition Therapeutics
CGTX
$97M
$18.2K ﹤0.01%
+10,000
New +$20.6K
BA icon
3853
PUT
Boeing
BA
$184B
$18K ﹤0.01%
100
-100
-50% -$20.5K
LICY
3854
DELISTED
Li-Cycle Holdings Corp.
LICY
$16.3K ﹤0.01%
1,979
-1,391
-41% -$6.25K
SPCE icon
3855
Virgin Galactic
SPCE
$498M
$16.2K ﹤0.01%
+547
New +$19.9K
DWSN icon
3856
Dawson Geophysical
DWSN
$138M
$15K ﹤0.01%
10,593
– –
FTH
3857
Faeth Therapeutics
FTH
$773M
$14.7K ﹤0.01%
700
– –
DWTX
3858
Dogwood Therapeutics
DWTX
$61.9M
$14.4K ﹤0.01%
1,200
– –
SENS icon
3859
Senseonics Holdings Inc
SENS
$416M
$14.1K ﹤0.01%
1,329
+594
+81% +$6.89K
POET icon
3860
POET Technologies
POET
$1.48B
$13.8K ﹤0.01%
10,100
– –
ATRA icon
3861
Atara Biotherapeutics
ATRA
$80.6M
$13.8K ﹤0.01%
796
+12
+2% +$213
SKYX icon
3862
SKYX Platforms
SKYX
$165M
$13.1K ﹤0.01%
10,000
– –
AKTS
3863
DELISTED
Akoustis Technologies Inc
AKTS
$12.6K ﹤0.01%
21,316
-75
-0.4% -$48
HELP
3864
Cybin Inc
HELP
$625M
$9.47K ﹤0.01%
+603
New +$8.71K
SGMO
3865
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$9.35K ﹤0.01%
+13,950
New +$10.1K
GEVO icon
3866
Gevo
GEVO
$403M
$8.22K ﹤0.01%
10,700
– –
VMAR icon
3867
Vision Marine Technologies
VMAR
$3.99M
– –
0
– –
MLSS icon
3868
Milestone Scientific
MLSS
$43M
$7.48K ﹤0.01%
12,000
– –
EVA
3869
DELISTED
Enviva Inc.
EVA
$7K ﹤0.01%
15,916
-3,525
-18% -$1.85K
PPBT
3870
Purple Biotech
PPBT
$2.52M
$6.7K ﹤0.01%
50
-5
-9% -$717
JOB icon
3871
GEE Group
JOB
$21.2M
$6.47K ﹤0.01%
18,000
– –
AZ icon
3872
A2Z Smart Technologies
AZ
$298M
$5.83K ﹤0.01%
4,000
– –
NEE icon
3873
PUT
NextEra Energy
NEE
$179B
$5.5K ﹤0.01%
100
– –
PVLA
3874
Palvella Therapeutics
PVLA
$2.22B
$5.5K ﹤0.01%
375
– –
DCFC
3875
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$1.49K ﹤0.01%
139
-2
-1% -$49
153 154
155
156 157

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James & Associates held 4,104 positions worth $148B, up 10% from $134B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2024 filing shows 267 new, 1,933 increased, 1,554 reduced and 192 closed positions. Its largest new stake was Veralto: 431,115 shares worth $38.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $233M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2024 buy was Veralto: 431,115 shares worth $38.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2024, an estimated $292M increase.
  • Raymond James & Associates's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $233M.
  • Raymond James & Associates fully exited Splunk Inc in Q1 2024, selling an estimated $14.6M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $148B portfolio in Q1 2024.
  • Raymond James & Associates opened 267 new positions and closed 192 in Q1 2024.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $148B.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.